Recently, HOTAIR high-expression was associated with acquired resistance to antileukemic drugs such as doxorubicin and immatinib [97,98], making this gene as a potential therapeutic target molecule that could contribute to solve a tremendous problem in leukemia chemotherapy, the drug-resistance. Here, HOTAIR is linked to leukemia.